Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions

Details for Australian Patent Application No. 2003240079 (hide)

International Classifications

Event Publications

11 September 2003 Complete Application Filed

Priority application(s): 0213669.5 14.06.02 GB

26 February 2004 Application Open to Public Inspection

Published as AU-B-2003240079

15 November 2007 Application Accepted

Published as AU-B-2003240079

13 March 2008 Standard Patent Sealed

5 June 2008 Assignment Registered

AstraZeneca AB The patent has been assigned to Albireo AB

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.